Showing 911-920 of 18562 results for "".
Soccer Injuries and How to Treat Them
https://reachmd.com/programs/focus-on-sports-medicine/soccer-injuries-and-how-to-treat-them/3670/The sports hernia is one of the most difficult injuries to diagnose and treat in elite soccer players. Join host Dr. Sherwin Ho as he talks with Dr. Riley Williams, associate professor of orthopedic surgery at Weill Medical College and medical director for the New York Red Bulls professional soccerTreating Brain Tumors with Immunotherapy
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/treating-brain-tumors-with-immunotherapy/12028/With brain cancer presenting its own unique set of challenges, how can we be sure that immunotherapy is the right treatment option?Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/Explore the potential of combining a nonsteroidal MRA & SGLT2i in patients with CKD & T2D with expert insights on data from the CONFIDENCE trial.Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
https://reachmd.com/programs/cme/optimizing-outcomes-in-patients-with-ohcm-the-emerging-role-of-cardiac-myosin-inhibitors/33176/Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin InhibitorsFrom Pixels to Practice: Advancing HCM Care With Multimodality Imaging
https://reachmd.com/programs/cme/from-pixels-to-practice-advancing-hcm-care-with-multimodality-imaging/39877/Explore how multimodality imaging advances diagnosis, treatment selection, and monitoring in hypertrophic cardiomyopathy care.Global Perspectives on Perioperative Immunotherapy in LA HNSCC
https://reachmd.com/programs/cme/global-perspectives-on-perioperative-immunotherapy-in-la-hnscc/36261/Global Perspectives on Perioperative Immunotherapy in LA HNSCCTargeting Mixed Hyperlipidemia with APOC3 Inhibition
https://reachmd.com/programs/cme/targeting-mixed-hyperlipidemia-with-apoc3-inhibition/33227/Listen to experts discussing the latest developments in APOC3 inhibition for the treatment of patients with FCS, SHTG, and mixed hyperlipidemia.Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
https://reachmd.com/programs/cme/breaking-down-the-benchmarks-pivotal-data-on-first-line-cdk46-inhibitors/39798/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Real-World Impact of Evolocumab on MACE Reduction in ASCVD
https://reachmd.com/clinical-practice/cardiology/real-world-impact-of-evolocumab-on-mace-reduction-in-ascvd/39991/Review real-world data on evolocumab and its association with reduced MACE in patients with established atherosclerotic cardiovascular disease.RSV in Infants and Young Children: Are You Taking It Seriously Enough?
https://reachmd.com/programs/cme/RSV-in-Infants-and-Young-Children-Are-You-Taking-It-Seriously-Enough/39306/Explore RSV prevention strategies in infants, including maternal immunization and monoclonal antibodies, aligned with current AAP guidelines.